We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
W. Brian Gibler, MD, FACEP, FACC, FAHA
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
David Seiffge, MD
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Reinforcement of Principles, Overcoming Treatment Barriers, and Improving Time to Treatment for ICH
Audience Q&A
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education